Marcela Moscoso-Vasquez

Marcela Moscoso-Vasquez

Auto-generated profile, based on publicly available information

Marcela Moscoso-Vasquez

Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2018 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
RSRicardo Sánchez-Peña
Ricardo Sánchez-Peña
PCPatricio Colmegna
Patricio Colmegna
FGFabricio Garelli
Fabricio Garelli
HBHernán De Battista
Hernán De Battista
DGDemián García-Violini
Demián García-Violini
LGLuis Grosembacher
Luis Grosembacher
Background: Emerging therapies such as closed-loop (CL) glucose control, also known as artificial pancreas (AP) systems, have shown significant improvement in type 1 diabetes mellitus (T1DM) management. However, demanding patient intervention is still required, particularly at meal times. To reduce treatment burden, the automatic regulation of glucose (ARG) algorithm mitigates postprandial glucose excursions without feedforward insulin boluses. This work assesses feasibility of this new strategy in a clinical trial. Methods: A 36-hour pilot study was performed on five T1DM subjects to validate the ARG algorithm. Subjects wore a subcutaneous continuous glucose monitor (CGM) and an insulin pump. Insulin delivery was solely commanded by the ARG algorithm, without premeal insulin boluses. This was the first clinical trial in Latin America to validate an AP controller. Results: For the total 36-hour period, results were as follows: average time of CGM readings in range 70-250 mg/dl: 88.6%, in range 70-180 mg/dl: 74.7%, <70 mg/dl: 5.8%, and <50 mg/dl: 0.8%. Results improved analyzing the final 15-hour period of this trial. In that case, the time spent in range was 70-250 mg/dl: 94.7%, in range 70-180 mg/dl: 82.6%, <70 mg/dl: 4.1%, and <50 mg/dl: 0.2%. During the last night the time spent in range was 70-250 mg/dl: 95%, in range 70-180 mg/dl: 87.7%, <70 mg/dl: 5.0%, and <50 mg/dl: 0.0%. No severe hypoglycemia occurred. No serious adverse events were reported. Conclusions: The ARG algorithm was successfully validated in a pilot clinical trial, encouraging further tests with a larger number of patients and in outpatient settings.

27 January 2020 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
MMMarcela Moscoso-Vasquez
Marcela Moscoso-Vasquez
PCPatricio Colmegna
Patricio Colmegna
NRNicolas Rosales
Nicolas Rosales
FGFabricio Garelli
Fabricio Garelli
RSRicardo Sanchez-Pena
Ricardo Sanchez-Pena
In this work, a low-order model designed for glucose regulation in T1DM is obtained from the UVA/Padova metabolic simulator. It captures not only the nonlinear behavior of the glucose-insulin system, but also intra-patient variations related to daily insulin sensitivity ( ${S_{I}}$ ) changes. To overcome the large inter-subject variability, the model can also be personalized based on a priori patient information. The structure is amenable for linear parameter varying (LPV) controller design, and represents the dynamics from the subcutaneous insulin input to the subcutaneous glucose output. The efficacy of this model is evaluated in comparison with a previous control-oriented model which in turn is an improvement of previous models. Both models are compared in terms of their open- and closed-loop differences with respect to the UVA/Padova model. The open-loop analysis is computed through the root mean square error (RMSE) between the glucose deviation predicted by the models and the UVA/Padova simulator. In closed-loop, the ν-gap metric is used to measure the distance in terms of closed-loop performance between the two models. The results are promising and some illustrative simulations are presented.

3 February 2025 in Diabetes Technology & Therapeutics
Verified
Journal Article
Closed access
MMMarcela Moscoso-Vasquez
Marcela Moscoso-Vasquez
PCPatricio Colmegna
Patricio Colmegna
CBCharlotte Barnett
Charlotte Barnett
MFMorgan Fuller
Morgan Fuller
CKChaitanya L.K. Koravi
Chaitanya L.K. Koravi
MBMarc D. Breton
Marc D. Breton
Background: Automated insulin delivery (AID) is widely available to people with type 1 diabetes (T1D), providing superior glycemic control versus traditional methods. The next generation of AID devices focus on minimizing user/device interactions, especially around meals (“full closed loop,” [FCL]). Our goal was to assess the postprandial glycemic impact of the bolus priming system (BPS), an algorithm delivering fixed insulin doses based on the likelihood of a meal having occurred, in conjunction with UVA’s latest AID. Method: Eleven adults with T1D participated in a supervised randomized-crossover trial assessing glycemic control during two 24-h sessions with identical meals and activity—with and without BPS. On the day in-between study sessions, participants underwent food and activity challenges to test BPS safety and robustness. Continuous glucose monitor (CGM) outcomes and total insulin doses were assessed overall and following meals with potential for BPS to dose additional insulin (CGM >90 mg/dL for 1 h prior). Results: Daytime CGM outcomes were similar with and without BPS: time-in-range (TIR) 70–180 mg/dL 70.6% [62.2–76.5] versus 65.7% [58.6%–80.6%]; time-below-range <70 mg/dL 0% [0–2.1] versus 0% [0–1.3]; respectively. Insulin delivery during 3 h postprandial was indistinguishable 33.5 U [26.4–47.0] versus 35.7 U [28.7–44.9]. Among 43 out of 66 meals with potential to trigger BPS (24/19 BPS/no-BPS), postprandial incremental area-under-the-curve (iAUC) was lower for BPS versus no-BPS (2530 ± 1934 versus 3228 ± 2029, P = 0.047), but CGM outcomes were inconclusive: 4-h-TIR 51.2% [19.8–83.3] versus 40.2% [20.8–56.3] ( P = 0.24). There were no severe adverse events. Conclusion: While there was no difference in TIR, when BPS was active an improved postprandial AUC in FCL was obtained via earlier insulin injection.

20 May 2014 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
Gloria Milena Monsalve BravoGloria Milena Monsalve Bravo
Gloria Milena Monsalve Bravo
HMHilda M. Moscoso-Vasquez
Hilda M. Moscoso-Vasquez
HAHernan Alvarez
Hernan Alvarez

28 February 2019 in Journal of Process Control
Verified
Journal Article
Closed access
FBFernando D. Bianchi
Fernando D. Bianchi
MMMarcela Moscoso-Vásquez
Marcela Moscoso-Vásquez
PCPatricio Colmegna
Patricio Colmegna
RSRicardo S. Sánchez-Peña
Ricardo S. Sánchez-Peña

18 December 2014 in Industrial & Engineering Chemistry Research
Verified
Journal Article
Closed access
HMHilda M. Moscoso-Vasquez
Hilda M. Moscoso-Vasquez
Gloria Milena Monsalve BravoGloria Milena Monsalve Bravo
Gloria Milena Monsalve Bravo
HAHernan Alvarez
Hernan Alvarez